Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saizen on Cardiac Function in Transition Phase GHD
NCT01157793Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- Sep 2003
- Primary completion
- Feb 2005
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 4 trial of somatropin in growth hormone deficiency (GHD), sponsored by Merck KGaA. Started Sep 2003; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01157793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01157793.